More about

Hepatitis

News
March 06, 2025
2 min read
Save

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial

The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according to a study published in NEJM Evidence.

News
January 07, 2025
2 min read
Save

Hispanic patients with alcohol use disorder face greater odds for hepatitis, cirrhosis

Hispanic patients with alcohol use disorder face greater odds for hepatitis, cirrhosis

Hispanic patients hospitalized for alcohol use disorder were more likely to develop alcohol-associated hepatitis, decompensated cirrhosis and related complications compared with non-Hispanic white patients, according to published data.

News
September 09, 2024
7 min read
Save

Man presents with right-sided headaches, ocular pain and vesicular rash

Man presents with right-sided headaches, ocular pain and vesicular rash

A 64-year-old man presented to the emergency department at Lahey Hospital with a 6-day history of right-sided headaches, right ocular pain and vesicular rash.

News
July 10, 2024
1 min read
Save

Organ network to remove race, hepatitis C coefficients for evaluating organ function

Organ network to remove race, hepatitis C coefficients for evaluating organ function

The Organ Procurement and Transplantation Network has removed two variables – whether a potential organ donor is African American or Black or has tested positive for the hepatitis C virus – from methods to evaluate deceased donor organs.

News
May 16, 2024
4 min read
Save

CDC: Learning ‘ABCs of viral hepatitis’ may help boost early testing, vaccination

CDC: Learning ‘ABCs of viral hepatitis’ may help boost early testing, vaccination

During Hepatitis Awareness Month, the CDC and allied public health organizations launched educational campaigns to raise awareness of viral hepatitis, deflate stigma around the infection and encourage early testing and vaccination.

News
May 14, 2024
1 min read
Save

FDA rejects expanded use of Dynavax’s four-dose hepatitis B vaccine for hemodialysis

FDA rejects expanded use of  Dynavax’s four-dose hepatitis B vaccine for hemodialysis

The FDA has declined to approve Dynavax’s supplemental biologics license application for the expanded use of its four-dose hepatitis B vaccine regimen in adult patients on hemodialysis, according to a manufacturer’s press release.

News
May 10, 2024
7 min read
Save

Q&A: ‘False sense of safety’ contributes to rise in STDs after menopause

Q&A: ‘False sense of safety’ contributes to rise in STDs after menopause

In the past decade, STDs have increased among women aged at least 55 years, highlighting the importance of discussing sexual partners, sexual history and condom use with all patients, regardless of age.

News
February 28, 2024
7 min watch
Save

VIDEO: 7 general principles ‘help to frame’ routine preventive vaccination in IBD

VIDEO: 7 general principles ‘help to frame’ routine preventive vaccination in IBD

In a Healio video exclusive, Gil Y. Melmed, MD, MS, outlines seven principles supported by literature that “help to frame” how providers should address routine preventive vaccination for patients with inflammatory bowel disease.

News
February 20, 2024
2 min read
Save

Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients

Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients

An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity.

News
February 14, 2024
2 min read
Save

FDA grants fast track status to investigational bepirovirsen for chronic hepatitis B

FDA grants fast track status to investigational bepirovirsen for chronic hepatitis B

The FDA has granted fast track designation to GSK’s bepirovirsen, a triple action investigational antisense oligonucleotide, for the treatment of chronic hepatitis B virus infection, according to a manufacturer release.

View more